1. Home
  2. CYTK vs VIST Comparison

CYTK vs VIST Comparison

Compare CYTK & VIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • VIST
  • Stock Information
  • Founded
  • CYTK 1997
  • VIST 2017
  • Country
  • CYTK United States
  • VIST Mexico
  • Employees
  • CYTK N/A
  • VIST N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • VIST Oil & Gas Production
  • Sector
  • CYTK Health Care
  • VIST Energy
  • Exchange
  • CYTK Nasdaq
  • VIST Nasdaq
  • Market Cap
  • CYTK 4.6B
  • VIST 5.1B
  • IPO Year
  • CYTK 2004
  • VIST 2019
  • Fundamental
  • Price
  • CYTK $59.89
  • VIST $34.34
  • Analyst Decision
  • CYTK Buy
  • VIST Buy
  • Analyst Count
  • CYTK 16
  • VIST 3
  • Target Price
  • CYTK $76.73
  • VIST $65.00
  • AVG Volume (30 Days)
  • CYTK 2.5M
  • VIST 1.4M
  • Earning Date
  • CYTK 11-05-2025
  • VIST 10-22-2025
  • Dividend Yield
  • CYTK N/A
  • VIST N/A
  • EPS Growth
  • CYTK N/A
  • VIST 26.19
  • EPS
  • CYTK N/A
  • VIST 5.47
  • Revenue
  • CYTK $85,738,000.00
  • VIST $1,982,699,000.00
  • Revenue This Year
  • CYTK $363.61
  • VIST $38.98
  • Revenue Next Year
  • CYTK $64.08
  • VIST $18.03
  • P/E Ratio
  • CYTK N/A
  • VIST $6.42
  • Revenue Growth
  • CYTK 2635.74
  • VIST 49.52
  • 52 Week Low
  • CYTK $29.31
  • VIST $31.63
  • 52 Week High
  • CYTK $61.19
  • VIST $61.67
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 75.04
  • VIST 38.77
  • Support Level
  • CYTK $47.22
  • VIST $33.45
  • Resistance Level
  • CYTK $50.78
  • VIST $38.41
  • Average True Range (ATR)
  • CYTK 2.30
  • VIST 1.65
  • MACD
  • CYTK 0.66
  • VIST 0.10
  • Stochastic Oscillator
  • CYTK 90.55
  • VIST 12.14

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About VIST Vista Energy S.A.B. de C.V. each representing one series A share with no par value

Vista Energy SAB de CV is an independent oil and gas company. It is focused on shale oil and shale gas exploration at its main assets in Vaca Muerta. The company has operations in Argentina and Mexico. The company operates in a single segment- the exploration and production of Crude oil, Natural gas, and LPG. Geographically, It operates in Argentina and Mexico. it generates the majority of its revenue from Argentina.

Share on Social Networks: